77 related articles for article (PubMed ID: 24934453)
1. Functions of invariant NK T cells are modulated by TLR ligands and IFN-α.
Villanueva AI; Haeryfar SM; Mallard BA; Kulkarni RR; Sharif S
Innate Immun; 2015 Apr; 21(3):275-88. PubMed ID: 24934453
[TBL] [Abstract][Full Text] [Related]
2. Costimulatory activation of murine invariant natural killer T cells by toll-like receptor agonists.
Kulkarni RR; Villanueva AI; Elawadli I; Jayanth P; Read LR; Haeryfar SM; Sharif S
Cell Immunol; 2012; 277(1-2):33-43. PubMed ID: 22795895
[TBL] [Abstract][Full Text] [Related]
3. Role of marginal zone B lymphocytes in invariant NKT cell activation.
Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C
J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762
[TBL] [Abstract][Full Text] [Related]
4. Phosphatase PP4 Negatively Regulates Type I IFN Production and Antiviral Innate Immunity by Dephosphorylating and Deactivating TBK1.
Zhan Z; Cao H; Xie X; Yang L; Zhang P; Chen Y; Fan H; Liu Z; Liu X
J Immunol; 2015 Oct; 195(8):3849-57. PubMed ID: 26363053
[TBL] [Abstract][Full Text] [Related]
5. Innate and adaptive stimulation of murine diverse NKT cells result in distinct cellular responses.
Tripathi P; Sedimbi SK; Singh AK; Löfbom L; Issazadeh-Navikas S; Weiss S; Förster I; Karlsson MCI; Yrlid U; Kadri N; Cardell SL
Eur J Immunol; 2019 Mar; 49(3):443-453. PubMed ID: 30427069
[TBL] [Abstract][Full Text] [Related]
6. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific.
Wu J; Meng Z; Jiang M; Zhang E; Trippler M; Broering R; Bucchi A; Krux F; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
Immunology; 2010 Mar; 129(3):363-74. PubMed ID: 19922426
[TBL] [Abstract][Full Text] [Related]
8. Differential indirect activation of human invariant natural killer T cells by Toll-like receptor agonists.
Moreno M; Mol BM; von Mensdorff-Pouilly S; Verheijen RH; de Jong EC; von Blomberg BM; van den Eertwegh AJ; Scheper RJ; Bontkes HJ
Immunotherapy; 2009 Jul; 1(4):557-70. PubMed ID: 20635987
[TBL] [Abstract][Full Text] [Related]
9. Activation of decidual invariant natural killer T cells promotes lipopolysaccharide-induced preterm birth.
Li L; Yang J; Jiang Y; Tu J; Schust DJ
Mol Hum Reprod; 2015 Apr; 21(4):369-81. PubMed ID: 25589517
[TBL] [Abstract][Full Text] [Related]
10. CpG oligonucleotide-mediated co-stimulation of mouse invariant natural killer T cells negatively regulates their activation status.
Kulkarni RR; Villanueva AI; Read LR; Brisbin JT; Bhaumik SK; LaMarre J; Murali-Krishna K; Sharif S
Cell Tissue Res; 2017 Sep; 369(3):541-554. PubMed ID: 28550425
[TBL] [Abstract][Full Text] [Related]
11. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways.
Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K
Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654
[TBL] [Abstract][Full Text] [Related]
12. TLR Ligand-Induced Type I IFNs Affect Thymopoiesis.
Baron ML; Gauchat D; La Motte-Mohs R; Kettaf N; Abdallah A; Michiels T; Zúñiga-Pflücker JC; Sékaly RP
J Immunol; 2008 Jun; 180(11):7134-46. PubMed ID: 18490712
[TBL] [Abstract][Full Text] [Related]
13. Generation and sustained expansion of mouse spleen invariant NKT cell lines with preserved cytokine releasing capacity.
Molling JW; Moreno M; van der Vliet HJ; von Blomberg BM; van den Eertwegh AJ; Scheper RJ; Bontkes HJ
J Immunol Methods; 2007 Apr; 322(1-2):70-81. PubMed ID: 17343874
[TBL] [Abstract][Full Text] [Related]
14. Activation of invariant natural killer T cells by α-galactosylceramide ameliorates myocardial ischemia/reperfusion injury in mice.
Homma T; Kinugawa S; Takahashi M; Sobirin MA; Saito A; Fukushima A; Suga T; Takada S; Kadoguchi T; Masaki Y; Furihata T; Taniguchi M; Nakayama T; Ishimori N; Iwabuchi K; Tsutsui H
J Mol Cell Cardiol; 2013 Sep; 62():179-88. PubMed ID: 23774048
[TBL] [Abstract][Full Text] [Related]
15. Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model.
Fujita H; Teng A; Nozawa R; Takamoto-Matsui Y; Katagiri-Matsumura H; Ikezawa Z; Ishii Y
J Immunol; 2009 Jul; 183(1):254-60. PubMed ID: 19542437
[TBL] [Abstract][Full Text] [Related]
16. CpG and poly(I:C) stimulation of dendritic cells and fibroblasts limits herpes simplex virus type 1 infection in an IFNβ-dependent and -independent way.
Gaajetaan GR; Geelen TH; Grauls GE; Bruggeman CA; Stassen FR
Antiviral Res; 2012 Jan; 93(1):39-47. PubMed ID: 22057305
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication.
Wang B; Trippler M; Pei R; Lu M; Broering R; Gerken G; Schlaak JF
J Hepatol; 2009 Dec; 51(6):1037-45. PubMed ID: 19716616
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses.
Ghosh TK; Mickelson DJ; Fink J; Solberg JC; Inglefield JR; Hook D; Gupta SK; Gibson S; Alkan SS
Cell Immunol; 2006 Sep; 243(1):48-57. PubMed ID: 17250816
[TBL] [Abstract][Full Text] [Related]
19. Evidence for dissociation of TLR mRNA expression and TLR agonist-mediated functions in bovine macrophages.
Franchini M; Schweizer M; Mätzener P; Magkouras I; Sauter KS; Mirkovitch J; Peterhans E; Jungi TW
Vet Immunol Immunopathol; 2006 Mar; 110(1-2):37-49. PubMed ID: 16216336
[TBL] [Abstract][Full Text] [Related]
20. Invariant natural killer T (iNKT) cells in asthma: a novel insight into the pathogenesis of asthma and the therapeutic implication of glycolipid ligands for allergic diseases.
Oki S; Miyake S
Allergol Int; 2007 Mar; 56(1):7-14. PubMed ID: 17259804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
